The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Dolgova I.G.

Tjumenskiĭ oblastnoĭ tsentr rassejannogo skleroza, Tjumenskiĭ oblastnoĭ oftalmologicheskiĭ dispanser, Tjumen;
GBOU VPO «Rossiĭskiĭ natsionalnyĭ issledovatelskiĭ meditsinskiĭ universitet im. N.I. Pirogova», Moskva

Malishevskaia T.N.

GAUZ Tiumenskoĭ oblasti "Oblastnoĭ oftal'mologicheskiĭ dispanser", Tiumen'

Rybina I.M.

GAUZ Tiumenskoĭ oblasti "Oblastnoĭ oftal'mologicheskiĭ dispanser", Tiumen'

Experience of Lucentis use in patients with wet age-related macular degeneration

Authors:

Dolgova I.G., Malishevskaia T.N., Rybina I.M.

More about the authors

Journal: Russian Annals of Ophthalmology. 2012;128(5): 26‑31

Read: 6898 times

Download PDF (RU)
Contact the author
Table of contents

EXPERIENCE OF LUCENTIS USE IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION
EXPERIENCE OF LUCENTIS USE IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION

To cite this article:

Dolgova IG, Malishevskaia TN, Rybina IM. Experience of Lucentis use in patients with wet age-related macular degeneration. Russian Annals of Ophthalmology. 2012;128(5):26‑31. (In Russ.)

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Obje­ctive stru­ctural and functional moni­toring of poly­peptide reti­nal neuroprotective therapy in diabetic reti­nopathy. Russian Annals of Ophthalmology. 2024;(5):97-104
Non-invasive auto­mated methods for the diagnosis of periorbital skin tumors. Russian Annals of Ophthalmology. 2024;(5):137-145
Effi­cacy of brolucizumab in the treatment of reti­nal pathologies: a review of post-marketing studies. Russian Annals of Ophthalmology. 2024;(5):154-161
Mana­gement of patients with treatment-resistant neovascular age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2024;(6):63-68
Pathogenetic aspe­cts of diffuse lame­llar kera­titis after laser corneal refractive surgery. Russian Annals of Ophthalmology. 2024;(6):131-137
Neuroprotective therapy for age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2024;(6):152-158
Cyto­megalovirus chorioretinitis in human immu­nodeficiency virus (case study). Russian Annals of Ophthalmology. 2025;(1):62-68
The role of the stru­cture of the lamina cribrosa in the diagnosis and treatment of glaucoma. Stru­ctural and circulatory changes in the lamina cribrosa with aging and elevated intraocular pressure. Russian Annals of Ophthalmology. 2025;(1):76-82
Choroidal neovascularization asso­ciated with choroidal nevi. Russian Annals of Ophthalmology. 2025;(1):104-112
Morphometric analysis of small reti­noblastomas following combination chemotherapy. Russian Annals of Ophthalmology. 2025;(2):38-43
Abstract:

This article provides information about development and introduction of regional standard of specialized medical care for patients with neovascular age-related macular degeneration in medical practice in Tumen region. It discovered new opportunities for improvement of ophthalmologic care in the region.

Keywords:

neovascularization
age-related macular degeneration
standard care
optical coherence tomography

Authors:

Dolgova I.G.

Tjumenskiĭ oblastnoĭ tsentr rassejannogo skleroza, Tjumenskiĭ oblastnoĭ oftalmologicheskiĭ dispanser, Tjumen;
GBOU VPO «Rossiĭskiĭ natsionalnyĭ issledovatelskiĭ meditsinskiĭ universitet im. N.I. Pirogova», Moskva

Malishevskaia T.N.

GAUZ Tiumenskoĭ oblasti "Oblastnoĭ oftal'mologicheskiĭ dispanser", Tiumen'

Rybina I.M.

GAUZ Tiumenskoĭ oblasti "Oblastnoĭ oftal'mologicheskiĭ dispanser", Tiumen'

Close metadata

References:

  1. Alpatov S.A., Shchuko A.G., Urneva E.M. Vozrastnaya makulyarnaya degeneratsiya. M: GEOTAR-Media 2010.
  2. Oftal'mologiya: Natsional'noe Rukovodstvo. pod red. S.E. Avetisova, E.A. Egorova, L.K. Moshetovoi i dr. M: GEOTAR-Media 2008; 141-147.
  3. Shchuko A.G., Malysheva V.V. Opticheskaya kogerentnaya tomografiya v diagnostike glaznykh boleznei. M: GEOTAR-Media 2010.
  4. Brawn D., Michels M., Kaiser P. Ranibizumab versus Verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009; 116: 57-65.
  5. Hee M., Izatt J., Swanson E. Optical coherence tomography of the human retina. Arch Ophthalmol 1995; 113: 3: 325-332
  6. Rosenfeld P., Brawn D., Heier J. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-1431.
  7. Schuman J.S., Puliafito C.A., Fujumoto J.G. Optical Coherence Tomography of ocular diseases. 2nd ed. NJ: Slack inc. Thorafore, 2004.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.